Preferred Label : edoxaban;

MeSH note : anticoagulant;

CISMeF synonym : DU-176b; DU-176; N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)ethanediamide p-toluenesulfonate monohydrate; ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-((1S,2R,4S)-4- ((dimethylamino)carbonyl)- 2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-C)pyridin-2-yl)carbonyl)amino)cyclohexyl)-;

MeSH synonym : N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide;

MeSH Related Number : 480449-70-5; 32W99UE810; 480449-70-5 (edoxaban);

Registry Number MeSH : 480449-70-5;

Is substance : O;

UNII : NDU3J18APO;

Details


Main resources

You can consult :


https://pharmactuel.com/index.php/pharmactuel/article/view/1261
2019
false
false
false
Canada
neoplasms
Factor Xa Inhibitors
edoxaban
critical appraisal or critical reading
comparative effectiveness research
dalteparin
anticoagulants
journal article
venous thromboembolism
edoxaban
pyridines
thiazoles

---
https://ansm.sante.fr/informations-de-securite/Anticoagulants-Oraux-Directs-AODs-apixaban-Eliquis-R-rivaroxaban-Xarelto-R-dabigatran-Pradaxa-R-et-edoxaban-Lixiana-R-Roteas-R-non-recommandes-chez-les-patients-presentant-un-Syndrome-des-Antiphospholipides-SAPL
2019
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
administration, oral
apixaban
Rivaroxaban
edoxaban
anticoagulants
Dabigatran
recurrence
risk
antiphospholipid syndrome
thrombosis
thrombosis
pyrazoles
pyridones
pyridines
thiazoles

---
https://www.has-sante.fr/portail/jcms/c_2826827/fr/lixiana
2018
false
false
false
France
French
English
treatment outcome
edoxaban
Edoxaban Tosylate
administration, oral
stroke
embolism
adult
risk factors
atrial fibrillation
deep vein thrombosis
deep vein thrombosis
recurrence
pulmonary embolism
pulmonary embolism
hemorrhage
edoxaban
hemorrhage
Factor Xa Inhibitors
edoxaban
evaluation of the transparency committee
venous thrombosis
venous thrombosis
pyridines
thiazoles
pyridines
thiazoles

---
https://www.has-sante.fr/portail/jcms/c_2851086/fr/les-anticoagulants-oraux
2018
false
false
false
France
French
guidelines for drug use
anticoagulants
anticoagulants
administration, oral
antivitamins K
antivitamins K
atrial fibrillation
drug overdose
apixaban
Dabigatran
antithrombins
Factor Xa Inhibitors
Rivaroxaban
edoxaban
Direct factor Xa inhibitors
direct thrombin inhibitors
pregnancy
patient compliance
continuity of patient care
hemorrhage
surgical procedures, operative
blood loss, surgical
hemorrhage
vitamin k antagonists
fluindione
acenocoumarol
warfarin
pyridines
thiazoles
phenindione
phenindione
indenes
4-hydroxycoumarins
vitamin K
vitamin K
indenes
4-hydroxycoumarins
vitamin K
pyrazoles
pyridones

---
https://www.ema.europa.eu/medicines/human/EPAR/Roteas
2017
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
edoxaban
edoxaban
Edoxaban Tosylate
Edoxaban Tosylate
drug approval
europe
product surveillance, postmarketing
administration, oral
stroke
embolism
adult
risk factors
atrial fibrillation
deep vein thrombosis
deep vein thrombosis
recurrence
pulmonary embolism
pulmonary embolism
drug interactions
pregnancy
breast feeding
hemorrhage
Edoxaban Tosylate
hemorrhage
Factor Xa Inhibitors
Factor Xa Inhibitors
edoxaban
drug evaluation, preclinical
drug evaluation
venous thrombosis
venous thrombosis
pyridines
thiazoles
pyridines
thiazoles

---
http://kce.fgov.be/fr/publication/report/anticoagulation-et-fibrillation-auriculaire
2017
false
false
false
Belgium
French
anticoagulants
anticoagulants
atrial fibrillation
treatment outcome
stroke
continuity of patient care
Cost-Benefit analysis
medication adherence
risk assessment
hemorrhage
vitamin K
antivitamins K
Rivaroxaban
edoxaban
Dabigatran
apixaban
Factor Xa Inhibitors
antithrombins
belgium
technical report
drug information
comparative study
anticoagulants
economic evaluation
drug monitoring
new oral anticoagulant
indenes
4-hydroxycoumarins
pyridines
thiazoles
pyrazoles
pyridones

---
https://www.minerva-ebp.be/FR/Article/2012
2016
false
false
false
false
Belgium
French
critical appraisal or critical reading
atrial fibrillation
stroke
pulmonary embolism
anticoagulants
anticoagulotherapy
administration, oral
edoxaban
treatment outcome
warfarin

---
http://www.has-sante.fr/portail/jcms/c_2658576/fr/lixiana-avc-fanv
http://www.has-sante.fr/portail/jcms/c_2658576/fr/lixiana-avc-fanv-edoxaban-anticoagulant-par-voie-orale
2016
false
false
false
France
French
evaluation of the transparency committee
administration, oral
edoxaban
edoxaban
Factor Xa Inhibitors
Factor Xa Inhibitors
risk factors
adult
embolism
treatment outcome
edoxaban
insurance, health, reimbursement
atrial fibrillation
aged
guidelines for drug use
stroke
pyridines
thiazoles
pyridines
thiazoles

---
http://www.has-sante.fr/portail/jcms/c_2658504/fr/lixiana-mtev
http://www.has-sante.fr/portail/jcms/c_2658504/fr/lixiana-mtev-edoxaban-anticoagulant-par-voie-orale
2016
false
false
false
France
French
evaluation of the transparency committee
deep vein thrombosis
deep vein thrombosis
recurrence
adult
administration, oral
pulmonary embolism
pulmonary embolism
edoxaban
edoxaban
edoxaban
treatment outcome
insurance, health, reimbursement
Factor Xa Inhibitors
Factor Xa Inhibitors
guidelines for drug use
venous thromboembolism
venous thrombosis
venous thrombosis
pyridines
thiazoles
pyridines
thiazoles

---
https://www.revmed.ch/RMS/2016/RMS-N-542/Anticoagulants-oraux-directs-ACOD-une-aide-a-la-prescription-dans-la-pratique-quotidienne
2016
false
false
false
Switzerland
French
journal article
venous thromboembolism
antithrombins
administration, oral
atrial fibrillation
Evidence-Based medicine
guidelines for drug use
recurrence
venous thromboembolism
antithrombins
Direct factor Xa inhibitors
Factor Xa Inhibitors
Factor IIa
dabigatran etexilate
Dabigatran
Rivaroxaban
apixaban
edoxaban
drug interactions
continuity of patient care
clinical chemistry tests
kidney function tests
hemorrhage
surgical procedures, operative
heparin
antivitamins K
patient safety
factor IIa
prothrombin
pyrazoles
pyridones
pyridines
thiazoles
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
https://www.revmed.ch/RMS/2016/RMS-N-529/Anticoagulants-oraux-directs-quelques-considerations-pratiques
2016
false
false
false
Switzerland
French
journal article
administration, oral
anticoagulants
thromboembolism
thromboembolism
Direct factor Xa inhibitors
direct thrombin inhibitors
aged
neoplasms
liver cirrhosis
obesity
continuity of patient care
drug interactions
antidotes
stroke
treatment outcome
anticoagulants
Dabigatran
Rivaroxaban
apixaban
edoxaban
anticoagulants
Contraindications, Procedure
pyrazoles
pyridones
pyridines
thiazoles
Contraindications, Drug

---
https://www.ema.europa.eu/medicines/human/EPAR/Lixiana
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
edoxaban
edoxaban
Edoxaban Tosylate
Edoxaban Tosylate
drug approval
europe
product surveillance, postmarketing
administration, oral
stroke
embolism
adult
risk factors
atrial fibrillation
deep vein thrombosis
deep vein thrombosis
recurrence
pulmonary embolism
pulmonary embolism
drug interactions
pregnancy
breast feeding
hemorrhage
edoxaban
Edoxaban Tosylate
hemorrhage
Factor Xa Inhibitors
Factor Xa Inhibitors
Factor Xa Inhibitors
edoxaban
drug evaluation, preclinical
venous thrombosis
venous thrombosis
pyridines
thiazoles
pyridines
thiazoles
pyridines
thiazoles

---
https://www.jle.com/fr/revues/medecine/met/e-docs/00/04/99/39/resume.phtml
2014
false
France
French
atrial fibrillation
anticoagulants
journal article
thrombosis
vitamin K
drug interactions
practice guideline
aged
risk assessment
apixaban
edoxaban
pyridines
thiazoles
pyrazoles
pyridones
antithrombins
anticoagulotherapy
Rivaroxaban
Dabigatran
antivitamins K
indenes
4-hydroxycoumarins

---
http://www.sciencedirect.com/science/article/pii/S0755498214002590
2014
false
false
false
France
French
atrial fibrillation
anticoagulants
administration, oral
anticoagulants
drug interactions
journal article
dabigatran etexilate
rivaroxaban
apixaban
apixaban
edoxaban
warfarin
factor xa
antithrombins
treatment outcome
renal insufficiency
age factors
Direct current cardioversion (procedure)
myocardial infarction
surgical procedures, operative
Factor Xa Inhibitors
anticoagulotherapy
Dabigatran
Rivaroxaban
pyridines
pyrazoles
pyridones
thiazoles

---
https://rmlg.uliege.be/article/2463
2013
false
true
false
Belgium
French
journal article
venous thromboembolism
venous thromboembolism
venous thromboembolism
hematologic agents
factor xa
thiazoles
pyridines
pyridines
pyridines
pyridines
thiazoles
thiazoles
thiazoles
venous thromboembolism
edoxaban
warfarin

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.